Jason PesterfieldFounder

United States - Austin, Texas

At Elucent we enable soft tissue oncologic surgeons with the Power of Precision with our first-of-kind Intelligent Spatial Guidance (iSG) navigation system that wirelessly integrates with surgeons existing surgical tools of choice, making them SmartTools, that are tracked and guided in real-time to the wireless SmartClip® in or around the tissue target with millimeter precision. We give surgeons confidence before, during, and after they treat.

I've had the honor and privilege of serving in the MedTech space for ~30 years with focus on leading efforts around developing and commercializing advanced diagnostic and surgical technologies. I've established a track record of building high-performance cultures, developing executable strategies, building talented teams, raising growth capital, and delivering results that create stakeholder value.

Prior to Elucent I served as President and CEO of Optellum which developed and commercialized the worlds first and only FDA cleared image based (CT) artificial intelligence (AI) biomarker for early stage lung cancer identification and prediction. Prior to Optellum I served as President and CEO of Veran Medical Technologies which developed and commercialized endobronchial and percutaneous navigation for early lung cancer diagnosis (acquired by Olympus). Prior to Veran I was with Stryker Corporation where I served in a variety of leadership positions, including Global Vice President and General Manager of the Surgical Navigation business with applications in Neuro, Spine, ENT, Knee, Hip, Trauma, Extremities, and Sports Med.